CN114438155A - Preparation method and application of soybean, coffee and Chinese wolfberry bioactive peptide - Google Patents
Preparation method and application of soybean, coffee and Chinese wolfberry bioactive peptide Download PDFInfo
- Publication number
- CN114438155A CN114438155A CN202210030629.5A CN202210030629A CN114438155A CN 114438155 A CN114438155 A CN 114438155A CN 202210030629 A CN202210030629 A CN 202210030629A CN 114438155 A CN114438155 A CN 114438155A
- Authority
- CN
- China
- Prior art keywords
- coffee
- soybean
- medlar
- bioactive peptide
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 56
- 244000068988 Glycine max Species 0.000 title claims abstract description 54
- 235000010469 Glycine max Nutrition 0.000 title claims abstract description 54
- 230000000975 bioactive effect Effects 0.000 title claims abstract description 24
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 241001284615 Frangula californica Species 0.000 title claims description 6
- 244000241872 Lycium chinense Species 0.000 title claims description 6
- 235000015468 Lycium chinense Nutrition 0.000 title claims description 6
- 235000004433 Simmondsia californica Nutrition 0.000 title claims description 6
- 235000017784 Mespilus germanica Nutrition 0.000 claims abstract description 48
- 244000182216 Mimusops elengi Species 0.000 claims abstract description 48
- 235000000560 Mimusops elengi Nutrition 0.000 claims abstract description 48
- 235000007837 Vangueria infausta Nutrition 0.000 claims abstract description 48
- 235000016213 coffee Nutrition 0.000 claims abstract description 47
- 235000013353 coffee beverage Nutrition 0.000 claims abstract description 47
- 239000002994 raw material Substances 0.000 claims abstract description 20
- 238000002156 mixing Methods 0.000 claims abstract description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 16
- 241000196324 Embryophyta Species 0.000 claims abstract description 14
- 102000004190 Enzymes Human genes 0.000 claims abstract description 11
- 108090000790 Enzymes Proteins 0.000 claims abstract description 11
- 229940088598 enzyme Drugs 0.000 claims abstract description 11
- 230000036541 health Effects 0.000 claims abstract description 9
- 230000000415 inactivating effect Effects 0.000 claims abstract description 9
- 239000008213 purified water Substances 0.000 claims abstract description 6
- 108090000526 Papain Proteins 0.000 claims abstract description 5
- 102000057297 Pepsin A Human genes 0.000 claims abstract description 5
- 108090000284 Pepsin A Proteins 0.000 claims abstract description 5
- 239000004365 Protease Substances 0.000 claims abstract description 5
- 102000004142 Trypsin Human genes 0.000 claims abstract description 5
- 108090000631 Trypsin Proteins 0.000 claims abstract description 5
- 239000012670 alkaline solution Substances 0.000 claims abstract description 5
- 235000013305 food Nutrition 0.000 claims abstract description 5
- 229940055729 papain Drugs 0.000 claims abstract description 5
- 235000019834 papain Nutrition 0.000 claims abstract description 5
- 229940111202 pepsin Drugs 0.000 claims abstract description 5
- 239000012588 trypsin Substances 0.000 claims abstract description 5
- 239000000796 flavoring agent Substances 0.000 claims abstract description 4
- 235000013355 food flavoring agent Nutrition 0.000 claims abstract description 4
- 239000004382 Amylase Substances 0.000 claims abstract description 3
- 102000013142 Amylases Human genes 0.000 claims abstract description 3
- 108010065511 Amylases Proteins 0.000 claims abstract description 3
- 240000003183 Manihot esculenta Species 0.000 claims abstract description 3
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 claims abstract description 3
- 235000019418 amylase Nutrition 0.000 claims abstract description 3
- 239000002537 cosmetic Substances 0.000 claims abstract description 3
- 229940079593 drug Drugs 0.000 claims abstract description 3
- 239000003814 drug Substances 0.000 claims abstract description 3
- 239000003755 preservative agent Substances 0.000 claims abstract description 3
- 230000002335 preservative effect Effects 0.000 claims abstract description 3
- 239000012460 protein solution Substances 0.000 claims abstract description 3
- 229960001322 trypsin Drugs 0.000 claims abstract description 3
- 240000007154 Coffea arabica Species 0.000 claims description 43
- 150000001875 compounds Chemical class 0.000 claims description 14
- 239000002131 composite material Substances 0.000 claims description 13
- 239000007788 liquid Substances 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 8
- 102000004169 proteins and genes Human genes 0.000 claims description 7
- 108090000623 proteins and genes Proteins 0.000 claims description 7
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 claims description 6
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 claims description 3
- URLZCHNOLZSCCA-VABKMULXSA-N Leu-enkephalin Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=CC=C1 URLZCHNOLZSCCA-VABKMULXSA-N 0.000 claims description 3
- 229960001948 caffeine Drugs 0.000 claims description 3
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 claims description 3
- 239000000047 product Substances 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- 239000012535 impurity Substances 0.000 claims description 2
- 235000013399 edible fruits Nutrition 0.000 claims 3
- 230000000694 effects Effects 0.000 abstract description 6
- 239000008280 blood Substances 0.000 abstract description 5
- 210000004369 blood Anatomy 0.000 abstract description 5
- 230000001105 regulatory effect Effects 0.000 abstract description 4
- 230000036039 immunity Effects 0.000 abstract description 3
- 230000001737 promoting effect Effects 0.000 abstract description 3
- 208000004930 Fatty Liver Diseases 0.000 abstract description 2
- 206010019708 Hepatic steatosis Diseases 0.000 abstract description 2
- 230000032683 aging Effects 0.000 abstract description 2
- 230000004438 eyesight Effects 0.000 abstract description 2
- 208000010706 fatty liver disease Diseases 0.000 abstract description 2
- 230000011132 hemopoiesis Effects 0.000 abstract description 2
- 230000002401 inhibitory effect Effects 0.000 abstract description 2
- 210000003734 kidney Anatomy 0.000 abstract description 2
- 150000002632 lipids Chemical class 0.000 abstract description 2
- 230000007774 longterm Effects 0.000 abstract description 2
- 230000035772 mutation Effects 0.000 abstract description 2
- 230000003860 sleep quality Effects 0.000 abstract description 2
- 231100000240 steatosis hepatitis Toxicity 0.000 abstract description 2
- 230000004614 tumor growth Effects 0.000 abstract description 2
- 241000723377 Coffea Species 0.000 abstract 4
- 239000000243 solution Substances 0.000 description 13
- 235000013373 food additive Nutrition 0.000 description 12
- 239000002778 food additive Substances 0.000 description 12
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 9
- 229930091371 Fructose Natural products 0.000 description 9
- 229960002737 fructose Drugs 0.000 description 9
- 239000005715 Fructose Substances 0.000 description 8
- 238000000108 ultra-filtration Methods 0.000 description 8
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 229940080701 chymosin Drugs 0.000 description 6
- 108010007119 flavourzyme Proteins 0.000 description 6
- 108010038807 Oligopeptides Proteins 0.000 description 5
- 102000015636 Oligopeptides Human genes 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 102000004196 processed proteins & peptides Human genes 0.000 description 5
- 108090000145 Bacillolysin Proteins 0.000 description 4
- 235000005976 Citrus sinensis Nutrition 0.000 description 4
- 240000002319 Citrus sinensis Species 0.000 description 4
- 108091005507 Neutral proteases Proteins 0.000 description 4
- 102000035092 Neutral proteases Human genes 0.000 description 4
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 4
- 235000019658 bitter taste Nutrition 0.000 description 4
- 229930189775 mogroside Natural products 0.000 description 4
- 229940013618 stevioside Drugs 0.000 description 4
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 4
- 235000019202 steviosides Nutrition 0.000 description 4
- 239000012528 membrane Substances 0.000 description 3
- 108091005658 Basic proteases Proteins 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 108010016626 Dipeptides Proteins 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 244000148687 Glycosmis pentaphylla Species 0.000 description 1
- 108010056079 Subtilisins Proteins 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 1
- 229940107187 fructooligosaccharide Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000007180 physiological regulation Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/011—Hydrolysed proteins; Derivatives thereof from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/145—Extraction; Separation; Purification by extraction or solubilisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Water Supply & Treatment (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Dermatology (AREA)
- General Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Urology & Nephrology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Biotechnology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
Abstract
The preparation method of the soybean, coffee and medlar bioactive peptide comprises the following steps of preparing raw materials of soybean, medlar and coffee: mixing 30-50 parts of soybean, 5-15 parts of medlar and 15-40 parts of coffee in proportion, firstly preparing a separated alkaline protein solution, separating the soybean, the medlar and the coffee, adding pepsin, trypsin, papain and cassava amylase into the alkaline solution, and inactivating enzyme after enzymolysis; the application is as follows: blending with purified water according to the proportion of 1-5%, adding flavoring agent, plant preservative and purified water to obtain raw materials, and making into cosmetics, foods or medicines and health products. The situation of insufficient vital essence is well nourished. The long-term administration can also clear fire, improve eyesight, tranquilize mind, improve sleep quality, and has effects of caring skin and prolonging life; the health condition of the body is effectively improved; it also has effects in regulating immunity, inhibiting tumor growth and cell mutation, delaying aging, preventing fatty liver, regulating blood lipid and blood sugar, promoting hematopoiesis, invigorating qi, and tonifying kidney.
Description
Technical Field
The invention relates to the field of preparation of bioactive peptides, in particular to a preparation method and application of bioactive peptides containing soybean, coffee and medlar.
Background
Bioactive Peptides (BAP) are a generic term for various Peptides ranging from dipeptides to complex linear, cyclic structures, composed of 20 natural amino acids in different compositions and arrangements in proteins, and are multifunctional compounds derived from proteins. The bioactive peptide has various human metabolism and physiological regulation functions, is easy to digest and absorb, has the effects of promoting immunity, hormone regulation, antibiosis, antivirus, blood pressure reduction, blood fat reduction and the like, and is a functional factor with the hottest research topic and great development prospect in the international food industry at present.
The existing bioactive peptide types do not take soybeans, medlar and coffee as raw materials, so that the bioactive peptide types are not rich enough, the nutritional ingredients are not diverse enough, and the requirements of consumers cannot be met.
Disclosure of Invention
Aiming at the defects in the prior art, the invention provides a preparation method and application of a bioactive peptide containing soybean, coffee and medlar.
In order to achieve the aim of the invention, the invention adopts the specific scheme that:
a preparation method of soybean, coffee and medlar bioactive peptide comprises the following steps of raw materials of soybean, medlar and coffee: mixing 30-50 parts of soybean, 5-15 parts of medlar and 15-40 parts of coffee in proportion, firstly preparing a separated alkaline protein solution, separating the soybean, the medlar and the coffee, adding pepsin, trypsin, papain and cassava amylase into the alkaline solution, carrying out enzymolysis, and then inactivating enzyme.
Furthermore, the protein raw materials of the soybeans, the medlar and the coffee are prepared by enzymolysis of pepsin and trypsin.
Further, the protein raw materials of the soybeans, the medlar and the coffee are prepared by papain or compound enzyme Protamex enzymolysis.
Further, the mass ratio of the soybean to the medlar to the caffeine and enkephalin is (1.3-3.1): (1.3-2.2): (1.8-4.1).
Further, the mass ratio of the soybean, medlar and coffee compound peptide is (1.3-4.0): 0.42.
further, removing surface impurities from the composite micromolecular ionic peptide liquid, centrifuging to obtain supernatant, and thus obtaining the composite soybean-medlar-coffee micromolecular (ionic) peptide.
The application of the bioactive peptide of soybean, coffee and medlar is to mix 1 to 5 percent of the ratio with purified water, add flavoring agent, plant preservative and purified water to obtain raw materials and prepare the raw materials into cosmetics, foods or medicines and health care products.
The invention has the beneficial effects that:
the invention prepares the composite plant micromolecule soybean, coffee and medlar peptide with a specific molecular weight range by a specific process, and the three or four of the composite plant micromolecule soybean, coffee and medlar peptide form a compound in a proper proportion, so that the composite plant micromolecule soybean, coffee and medlar peptide can well nourish the situation of insufficient essence and qi with a small using amount. The long-term administration can also clear fire, improve eyesight, tranquilize mind, improve sleep quality, and has effects of caring skin and prolonging life; the health-care food can be taken all the year round, so that the health condition is effectively improved; it also has effects in regulating immunity, inhibiting tumor growth and cell mutation, delaying aging, preventing fatty liver, regulating blood lipid and blood sugar, promoting hematopoiesis, invigorating qi, and tonifying kidney.
Detailed Description
The present invention is further described below by way of specific examples, but the present invention is not limited to only the following examples. Variations, combinations, or substitutions of the invention, which are within the scope of the invention or the spirit, scope of the invention, will be apparent to those of skill in the art and are within the scope of the invention.
A compound health promotion process using peptide health promotion function, coffee aroma and fructus Lycii health promotion effect is provided. Firstly, 30-70 parts of soybean, 5-15 parts of coffee and 15-40 parts of medlar are mixed to separate protein alkaline solution. Adding Alcalase protease into the alkaline solution obtained by separating soybean, coffee and medlar, performing enzymolysis, inactivating enzyme, centrifuging, and obtaining supernatant, namely the composite soybean coffee medlar peptide solution. Carrying out reflux ultrafiltration on the soybean, medlar, caffeine and enkephalin liquid in a greenhouse, and carrying out adsorption deodorization on activated carbon during the ultrafiltration. And performing series connection on 9 ultrafiltration membranes in the ultrafiltration operation to intercept molecular weight of 2500Da-4500Da and pressure of 0.2Mpa-1.2Mpa, treating for 5-20min, removing inorganic salt ions with relative molecular mass less than or equal to 2500Da, and collecting and filtering the soybean, coffee and Chinese wolfberry composite peptide liquid. And adding flavoring agents such as orange and strawberry liquid, fructo-oligosaccharide, xylitol, fruit sugar and the like in a greenhouse to improve the taste of the finished product of the compound peptide liquid. The oral liquid with health care and treatment functions is produced.
Example 1
The raw materials comprise the following components in parts by weight: 80 parts of compound soybean, medlar and coffee peptide, 2 parts of crystalline fructose and food additive.
The food additive is prepared by mixing the following raw materials in parts by weight: 0.5 part of sweet orange essence, 0.5 part of bitter taste reducing essence, 0.4 part of mogroside and 0.05 part of stevioside.
A preparation method of plant peptide comprises the following steps:
s1, dissolving the composite soybean medlar coffee peptide in water (the mass ratio of materials to water is 1:10), adjusting the pH of the solution to 8.5 by using 1mol/L NaOH solution, adding alkaline protease for enzymolysis, then adjusting the pH to 7 by using 1mol/L HC1 solution, adding neutral protease for enzymolysis, adding 2500U/kg of the neutral protease for enzymolysis, inactivating the enzyme after the enzymolysis is finished, centrifuging, taking supernate, and performing ultrafiltration by using an ultrafiltration membrane with the molecular weight cutoff of 1000U to obtain filtrate with the molecular weight of less than 1000U, thereby obtaining the soybean medlar coffee composite oligopeptide concentrated solution.
S2, mixing soybean, medlar and coffee oligopeptides, dissolving the soybean, medlar and coffee oligopeptides in water (the mass ratio of the materials to the water is 1:10), adjusting the pH to 7 by using 1mol/L HC1 solution, adding a-chymosin and flavourzyme for reaction, wherein the addition amount of the a-chymosin is 2000U/kg, the addition amount of the flavourzyme is 3000U/kg, inactivating enzymes after the reaction is finished, centrifuging, taking supernate, dialyzing, precooling for 50min at the temperature of-10 ℃ to obtain a composite peptide concentrated solution, adding crystalline fructose and a food additive, and dissolving and mixing uniformly to obtain the plant peptide oral liquid.
Example 2
The raw materials comprise the following components in parts by weight: 75 parts of soybean, medlar and coffee compound peptide, 15 parts of crystalline fructose and 1.5 parts of food additive.
The food additive is prepared by mixing the following raw materials in parts by weight: 0.5 part of sweet orange essence, 0.5 part of bitter taste reducing essence, 0.4 part of mogroside and 0.05 part of stevioside.
A preparation method of plant peptide comprises the following steps:
s1, dissolving soybean and medlar coffee peptide in water (the mass ratio of materials to water is 1:10), adjusting the pH of the solution to 8.5 by using 1mol/L NaOH solution, adding alkaline protease for enzymolysis, then adjusting the pH to 7 by using 1mol/L HC1 solution, adding neutral protease for enzymolysis, adding 2500U/kg of the neutral protease for enzymolysis, inactivating enzyme after the enzymolysis is finished, centrifuging, taking supernate, and performing ultrafiltration by using an ultrafiltration membrane with the molecular weight cutoff of 1000U to obtain filtrate with the molecular weight of less than 1000U, thereby obtaining the soybean and medlar coffee composite oligomeric liquid.
S2, mixing soybean, medlar and coffee oligopeptides, dissolving the soybean, medlar and coffee oligopeptides in water (the mass ratio of the materials to the water is 1:10), adjusting the pH to 6 by using 1mol/L HC1 solution, adding a-chymosin and flavourzyme for reaction, wherein the addition amount of the a-chymosin is 2000U/kg, the addition amount of the flavourzyme is 3000U/kg, inactivating enzyme after the reaction is finished, centrifuging, taking supernate to obtain a compound peptide concentrated solution, adding crystalline fructose and a food additive, and dissolving and mixing uniformly to obtain the plant peptide oral liquid.
Comparative example 1
The raw materials comprise the following components in parts by weight: 75 parts of soybean, medlar and coffee compound peptide, 15 parts of crystalline fructose and 1.5 parts of food additive.
The food additive is prepared by mixing the following raw materials in parts by weight: 0.5 part of sweet orange essence, 0.5 part of bitter taste reducing essence, 0.4 part of mogroside and 0.05 part of stevioside.
A preparation method of plant peptide comprises the following steps:
adding crystalline fructose and food additive into the soybean, medlar and coffee compound peptide, dissolving and mixing uniformly to prepare the plant peptide oral liquid.
Comparative example 2
The raw materials comprise the following components in parts by weight: 75 parts of soybean, medlar and coffee compound peptide, 15 parts of crystalline fructose and 1.5 parts of food additive.
The food additive is prepared by mixing the following raw materials in parts by weight: 0.5 part of sweet orange essence, 0.5 part of bitter taste reducing essence, 0.4 part of mogroside and 0.05 part of stevioside.
A preparation method of plant peptide comprises the following steps:
mixing soybean and medlar coffee peptides, dissolving the mixture in water (the mass ratio of the materials to the water is 1:10), adjusting the pH to 6 by using 1mol/L HC1 solution, adding a-chymosin and flavourzyme for reaction, wherein the addition amount of the a-chymosin is 2000U/kg, the addition amount of the flavourzyme is 3000U/kg, inactivating enzyme after the reaction is finished, centrifuging, taking supernate, adding crystalline fructose and food additives, and dissolving and mixing uniformly to prepare the plant peptide liquid oral liquid.
The above description is only for the purpose of illustrating the preferred embodiments of the present invention and is not to be construed as limiting the present invention, and any modifications, equivalents and improvements made within the spirit and principle of the present invention should be included in the scope of the present invention.
Claims (7)
1. A preparation method of soybean, coffee and medlar bioactive peptide is characterized in that the raw materials comprise soybean, medlar and coffee, and the specific method comprises the following steps: mixing 30-50 parts of soybean, 5-15 parts of medlar and 15-40 parts of coffee in proportion, firstly preparing a separated alkaline protein solution, separating the soybean, the medlar and the coffee, adding pepsin, trypsin, papain and cassava amylase into the alkaline solution, carrying out enzymolysis, and then inactivating enzyme.
2. The method for preparing the bioactive peptide of soybean, coffee and Chinese wolfberry fruit according to claim 1, wherein the bioactive peptide comprises the following components: the protein raw materials of the soybeans, the medlar and the coffee are prepared by enzymolysis of pepsin and trypsin.
3. The method for preparing the bioactive peptide of soybean, coffee and Chinese wolfberry fruit according to claim 1, wherein the bioactive peptide comprises the following components: the protein raw materials of the soybeans, the medlar and the coffee are prepared by papain or compound enzyme Protamex enzymolysis.
4. The method for preparing bioactive peptide from soybean, coffee and medlar according to any one of claims 1 to 3, wherein the bioactive peptide comprises the following components: the mass ratio of the soybeans to the medlar to the caffeine and enkephalin is (1.3-3.1): (1.3-2.2): (1.8-4.1).
5. The method for preparing bioactive peptide from soybean, coffee and medlar according to any one of claims 1 to 3, wherein the bioactive peptide comprises the following components: the mass ratio of the soybean, the medlar and the coffee compound peptide is (1.3-4.0): 0.42.
6. the method for preparing the bioactive peptide of soybean, coffee and Chinese wolfberry fruit according to claim 1, wherein the bioactive peptide comprises the following components: and removing surface impurities from the composite micromolecular ionic peptide liquid, and centrifuging to obtain supernatant, namely the composite soybean-medlar coffee micromolecular (ionic) peptide.
7. The application of the soybean, coffee and medlar bioactive peptide is characterized in that: blending with purified water according to the proportion of 1-5%, adding flavoring agent, plant preservative and purified water to obtain raw materials, and making into cosmetics, foods or medicines and health products.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210030629.5A CN114438155A (en) | 2022-01-12 | 2022-01-12 | Preparation method and application of soybean, coffee and Chinese wolfberry bioactive peptide |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210030629.5A CN114438155A (en) | 2022-01-12 | 2022-01-12 | Preparation method and application of soybean, coffee and Chinese wolfberry bioactive peptide |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114438155A true CN114438155A (en) | 2022-05-06 |
Family
ID=81367384
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210030629.5A Pending CN114438155A (en) | 2022-01-12 | 2022-01-12 | Preparation method and application of soybean, coffee and Chinese wolfberry bioactive peptide |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114438155A (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1489923A (en) * | 2003-09-16 | 2004-04-21 | 北京陶正生物工程技术有限公司 | Method for producing soya protein bioactive peptide |
CN104431208A (en) * | 2014-12-29 | 2015-03-25 | 陕西天宝大豆食品技术研究所 | Peptide coffee and preparation method thereof |
CN106868081A (en) * | 2016-12-13 | 2017-06-20 | 国肽生物科技(北京)有限公司 | The extracting method of lbp peptide |
CN107997186A (en) * | 2018-01-31 | 2018-05-08 | 天津天肽生物科技有限公司 | A kind of preparation method of matrimony vine polypeptide |
CN110037163A (en) * | 2019-04-24 | 2019-07-23 | 王书敏 | A kind of preparation method of compound plant protein peptide |
CN111358009A (en) * | 2020-03-16 | 2020-07-03 | 赵秋萍 | Plant peptide and preparation method and application thereof |
-
2022
- 2022-01-12 CN CN202210030629.5A patent/CN114438155A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1489923A (en) * | 2003-09-16 | 2004-04-21 | 北京陶正生物工程技术有限公司 | Method for producing soya protein bioactive peptide |
CN104431208A (en) * | 2014-12-29 | 2015-03-25 | 陕西天宝大豆食品技术研究所 | Peptide coffee and preparation method thereof |
CN106868081A (en) * | 2016-12-13 | 2017-06-20 | 国肽生物科技(北京)有限公司 | The extracting method of lbp peptide |
CN107997186A (en) * | 2018-01-31 | 2018-05-08 | 天津天肽生物科技有限公司 | A kind of preparation method of matrimony vine polypeptide |
CN110037163A (en) * | 2019-04-24 | 2019-07-23 | 王书敏 | A kind of preparation method of compound plant protein peptide |
CN111358009A (en) * | 2020-03-16 | 2020-07-03 | 赵秋萍 | Plant peptide and preparation method and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103598544B (en) | Extraction process for carrying out comprehensive utilization on garlic as raw material | |
US20220024974A1 (en) | Methods for producing a rice protein peptide and applications thereof | |
CN110205353A (en) | A kind of saline taste enhancing peptide and its preparation method and application | |
CN111642666A (en) | Preparation method of ginseng extract soybean peptide powder solid beverage | |
CN101238904B (en) | Chickpea bean sprout juice tea and preparation method and application | |
CN102440346A (en) | Protein nutritive jellies prepared from oviductus ranae enzymatic hydrolysate and byproduct | |
CN1377590A (en) | Method for producing soybean protein hydrolyate and use | |
CN102511890A (en) | Jellyfish beverage | |
CN101353687A (en) | Melissa powder peptides having angiotensin transferase inhibitory activity and preparation thereof | |
CN102125096A (en) | Pease milk powder capable of reducing blood pressure and preparation method thereof | |
CN103876163A (en) | Rana japonica meat composite protein powder and preparation method thereof | |
CN109757601B (en) | Sea cucumber peptide and production method thereof | |
CN114438155A (en) | Preparation method and application of soybean, coffee and Chinese wolfberry bioactive peptide | |
CN101130801A (en) | Preparation of active antihypertensive peptide product | |
CN111329988A (en) | Donkey-hide gelatin peptide buccal tablet rich in free arginine and preparation method thereof | |
CN111202246A (en) | Soybean oligopeptide powder and preparation method thereof | |
CN104757655A (en) | Earthworm amino acid beverage and preparation method thereof | |
CN110499351A (en) | A kind of soybean peptide and the preparation method and application thereof with high ACE inhibitory activity | |
CN105341315A (en) | Protein hydrolyzate preparation technology | |
CN114480539A (en) | Preparation method and application of soybean, coffee and ginseng bioactive peptides | |
CN114214380A (en) | Preparation method and application of soybean, coffee and American ginseng bioactive peptides | |
CN114480540A (en) | Preparation method and application of soybean, coffee and hawthorn bioactive peptide | |
CN114480536A (en) | Preparation method and application of soybean, coffee and sealwort bioactive peptide | |
CN114395596A (en) | Preparation method and application of soybean, coffee and ganoderma lucidum bioactive peptide | |
CN114517219A (en) | Preparation method and application of soybean, coffee and gastrodia elata bioactive peptide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220506 |